Uncategorised - European Medical Journal

Lifetime Management of Aortic Stenosis in Young Patients

The number of transcatheter aortic valve replacements/implantations (TAVR/TAVI) has nearly equalled that of the number of surgical aortic…

CSV/HSV Co-infection with Oesophageal Stricture in Young Immunocompetent Woman

The authors report the first case of oesophageal cytomegalovirus (CMV) and herpes simplex virus (HSV) co-infection in an immunocompetent…

ESC 2024 Interview: Lis Neubeck

I’ve been interested in alternative models to secondary prevention for a very long time. I’m very aware that not everybody gets access to cardiac rehabilitation, so I’ve been looking at digital models.

Cracking compliance in the US: Key points for pharma to remember

What key compliance considerations should pharma companies keep in mind before releasing new research in the US market, and how can they avoid compliance pitfalls?

AI Model Predicts Mortality Using Chest CT Findings

AN AI-BASED model can effectively predict all-cause mortality by identifying incidental extrapulmonary findings on chest CT scans according to a recent study.

MRI Biopsy Outperforms Other Techniques for Assessing Breast Abnormalities

This study suggests that contrast-enhanced mammography-guided biopsy is not a suitable substitute for MRI-guided biopsy in evaluating suspicious breast MRI findings

Congress Wrap: ESC 2024

The European Society of Cardiology (ESC) Congress 2024, held in London, UK, was a truly groundbreaking event, bringing together the brightest…

Onc Now: Episode 1: Choices in Cancer Care: Empowering Every Patient

In this podcast, Divyanshu Dua discusses the future of AI in oncology, as well as the importance of treatment options for older patients.

Identify and Manage an Interactive Osteoarthritis Case

Improve your awareness and management of patients with osteoarthritis using this interactive case study on a patient experiencing related symptoms

Potential Biomarker for Predicting Liver Cancer Immunotherapy Success

A recent study explores serum anti-PD-1 autoantibodies as a potential biomarker for predicting survival outcomes in patients with advanced hepatocellular carcinoma